IMS Health Names Mason Tenaglia Vice President, Payer & Managed Care Insights, IMS Institute For Healthcare Informatics

IMS Health (NYSE:IMS) today announced that Mason Tenaglia has been appointed vice president, Payer & Managed Care Insights, IMS Institute for Healthcare Informatics, a new position. In this role, Tenaglia is responsible for advancing the IMS Institute's payer and managed care thought leadership, as well as engaging with key leaders in the healthcare industry, academia and government.

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Polyphor is developing an inhaled version of murepavadin, which targets Pseudomonas aeruginosa infections, but is currently given intravenously.

Japanese pharma Astellas is looking to offload a series of unwanted research projects ahead of Thanksgiving; if you want one, it’s made it very easy.

A re-engineered adenovirus prolonged survival in mouse models of metastatic lung cancer and cleared tumors in about 35% of the animals.